-
1
المؤلفون: Javier Murillas, M. Cervantes, José Mallolas, S. López-Calvo, Josep M. Guardiola, Montserrat Laguno, Jordi Navarro, Carmen Cifuentes, Anna Cruceta, Ana Carrero, M.A. Von Wichmann, Juan A. Pineda, María Martínez-Rebollar, Elisabeth Deig, J.L. Gómez-Sirvent, Antoni Jou, E. Van den Eynde, A. Tapiz, Marisa Montes, J.D. Ruiz-Mesa, S. Veloso, E de Lazzari
المساهمون: [Laguno, M.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [Martinez-Rebollar, M.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [Cruceta, A.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [de lazzari, E.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [Mallolas, J.] Hosp Clin Barcelona, IDIBAPS, Villarroel 170, Barcelona, Spain, [Von Wichmann, M. A.] Hosp Univ Donostia, Donostia San Sebastian, Spain, [Van den Eynde, E.] Hosp Univ Bellvitge, Bellvitge, Spain, [Navarro, J.] Hosital Univ Vall dHebron, Barcelona, Spain, [Cifuentes, C.] Hosp Son Llatzer, Palma De Mallorca, Spain, [Murillas, J.] Hosp Son Espases, Palma De Mallorca, Spain, [Veloso, S.] Hosp Univ Joan XXIII, Tarragona, Spain, [Guardiola, J. M.] Hosp Santa Creu & Sant Pau, Barcelona, Spain, [Jou, A.] Hosp Badalona Germans Trias & Pujol, Badalona, Spain, [Gomez-Sirvent, J. L.] Hosp Univ Canarias, Tenerife, Spain, [Cervantes, M.] Corp Sanitaria Parc Tauli, Sabadell, Spain, [Pineda, J. A.] Hosp Univ Valme, Seville, Spain, [Lopez-Calvo, S.] Hosp Univ A Coruna, La Coruna, Spain, [Carrero, A.] Hosp Univ Gregorio Maranon, Madrid, Spain, [Montes, M. L.] Hosp Univ La Paz, Madrid, Spain, [Deig, E.] Hosp Granollers, Granollers, Spain, [Tapiz, A.] Fundacio Althaia, Manresa, Spain, [Ruiz-Mesa, J. D.] Hosp Reg, Malaga, Spain, Merck: BOC-HIV Study, Instituto de Salud Carlos III, Ministerio Economia y Competitividad
المصدر: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
International Journal of Infectious Diseases, Vol 53, Iss C, Pp 46-51 (2016)
Dipòsit Digital de la UB
Universidad de Barcelonaمصطلحات موضوعية: Peptidasas, Male, Cirrhosis, HIV Infections, interferón alfa, HCV genotype 1, Hepacivirus, Phase-2 trial, Oral inhibitors, Gastroenterology, Telaprevir, Polyethylene Glycols, 0302 clinical medicine, Pegylated interferon, estudios prospectivos, ribavirina, PEG-IFN/RBV plus BOC therapy, Clinical endpoint, VIH-VHC, Prospective Studies, mediana edad, Boceprevir, PEG-IFN therapy, Coinfection, farmacoterapia, virus diseases, General Medicine, adulto, Genotype 1, Interferon, retratamiento, 030211 gastroenterology & hepatology, Drug Therapy, Combination, Safety, Microbiology (medical), medicine.medical_specialty, 616.9, Genotype, Proline, Antiviral Agents, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, Drug Therapy, Humans, proteínas recombinantes, Pacients, Inhibidores orales, Adverse effect, HIV–HCV experienced patients, medicine.disease, digestive system diseases, Discontinuation, chemistry, proteínas víricas no estructurales, genotipo, Teràpia PEG-IFN, glicoles de polietileno, antivíricos, humanos, Interferó, Viral Nonstructural Proteins, medicine.disease_cause, Genotipo 1, chemistry.chemical_compound, prolina, PEG-IFN/RBV + BOC therapy, 030212 general & internal medicine, coinfección, resultado del tratamiento, Cohort, HIV-HCV experienced patients, Middle Aged, Hepatitis C, Recombinant Proteins, Infectious Diseases, Treatment Outcome, Retreatment, Pacientes, Female, Terapia PEG-IFN, medicine.drug, Adult, Patients, Hepatitis C virus, Coinfected patients, Interferon-alpha-2b, Re-treatment, Genotip 1, Internal medicine, Ribavirin, medicine, Triple-therapy, lcsh:RC109-216, PEG-IFN/RBV+BOC therapy, Espanya, business.industry, Interferon-alpha, Proteasa, Protease, Surgery, Inhibidors orals, RBV + BOC, Spain, infecciones por VIH, business
وصف الملف: application/pdf